Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Co. manufactures and sells products in the U.S. and selects international markets. Co.'s products include its Lightbox imaging console, the Ocelot family of catheters, which allows physicians to penetrate a total blockage in an artery, and Pantheris, a device that allows physicians to remove arterial plaque in PAD patients. Co. also provides the Wildcat family of catheters, which are used for crossing chronic total occlusions but do not contain on-board imaging technology. The AVGR stock yearly return is shown above.
The yearly return on the AVGR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the AVGR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|